226
Views
8
CrossRef citations to date
0
Altmetric
studies in humans

Relationship between plasma trans-fatty acid isomer concentrations and self-reported cardiovascular disease risk in US adults

, , , , & ORCID Icon
Pages 976-984 | Received 02 Dec 2017, Accepted 12 Jan 2018, Published online: 28 Jan 2018

References

  • Brouwer IA, Wanders AJ, Katan MB. 2013. Trans-fatty acids and cardiovascular health: research completed? Eur J Clin Nutr. 67:541–547.
  • Brouwer IA, Wanders AJ, Katan MB. 2010. Effect of animal and industrial trans-fatty acids on HDL and LDL cholesterol levels in humans-a quantitative review. PLoS ONE. 5:e9434
  • Bin Q, Rao H, Hu JN, Liu R, Fan YW, Li J, Deng ZY, Zhong X, Du FL. 2013. The caspase pathway of linoelaidic acid (9t, 12t-c18:2)-induced apoptosis in human umbilical vein endothelial cells. Lipids. 48:115–126.
  • Centers for Disease Control and Prevention (CDC). 2015. Questionnaires, Datasets, and Related Documentation. [Online]. [accessed 2017 August]. Available at: https://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm
  • Chardigny JM, Destaillats F, Malpuech-Brugère C, Moulin J, Bauman DE, Lock AL, Barbano DM. 2008. Do trans-fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans-fatty acids collaboration (TRANSFACT) study. Am J Clin Nutr. 87:558–566.
  • Chung HK, Cho Y, Do HJ, Oh K, Seo WK, Shin MJ. 2015. Plasma phospholipid arachidonic acid and lignoceric acid are associated with the risk of cardioembolic stroke. Nutr Res. 35:1001–1008.
  • Dawczynski C, Lorkowski S. 2016. Trans-fatty acids and cardiovascular risk: does origin matter? Expert Rev Cardiovasc Ther. 14:1001–1005.
  • Funck LG, Barrera-Arellano D, Block JM. 2006. Conjugated linoleic acid (CLA) and its relationship with cardiovascular disease and associated risk factors. Arch Latinoam Nutr. 56:123–134.
  • Gebauer SK, Destaillats F, Dionisi F, Krauss RM, Baer DJ. 2015. Vaccenic acid and trans-fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. Am J Clin Nutr. 102:1339–1346.
  • Gebauer SK, Psota TL, Kris-Etherton PM. 2007. The diversity of health effects of individual trans-fatty acid isomers. Lipids. 42:787–799.
  • Guasch-Ferré M, Babio N, Martínez-González MA, Corella D, Ros E, Martín-Peláez S, Estruch R, Arós F, Gómez-Gracia E, Fiol M, et al.; PREDIMED Study Investigators. 2015. Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease. Am J Clin Nutr. 102:1563–1573.
  • Harvey KA, Walker CL, Xu Z, Whitley P, Siddiqui RA. 2012. Trans-fatty acids: induction of a pro-inflammatory phenotype in endothelial cells. Lipids. 47:647–657.
  • He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, Ascherio A. 2003. Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ. 327:777–782.
  • Iso H, Stampfer MJ, Manson JE, Rexrode K, Hu F, Hennekens CH, Colditz GA, Speizer FE. 2001. Prospective study of fat and protein intake and risk of intraparenchymal hemorrhage in women. Circulation. 103:856–863.
  • Kiage JN, Merrill PD, Judd SE, He K, Lipworth L, Cushman M, Howard VJ, Kabagambe EK. 2014. Intake of trans-fat and incidence of stroke in the reasons for geographic and racial differences in stroke (REGARDS) cohort1–. Am J Clin Nutr. 99:1071–1076.
  • Lacroix E, Charest A, Cyr A, Lebeuf Y, Paquin P, Chouinard PY, Couture P, Lamarche B. 2012. Randomized controlled study of the effect of a butter naturally enriched in trans-fatty acids on blood lipids in healthy women. Am J Clin Nutr. 95:318–325.
  • Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P, McConnell JP. 2001. Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 73:38–45.
  • Li H, Zhang Q, Song J, Wang A, Zou Y, Ding L, Wen Y. 2017. Plasma trans-fatty acids levels and mortality: a cohort study based on 1999–2000 National Health and Nutrition Examination Survey (NHANES). Lipids Health Dis. 16:176
  • Li XP, Luo T, Li J, Fan YW, Liu R, Hu JN, Liu XR, Deng ZY. 2013. Linolelaidic acid induces a stronger proliferative effect on human umbilical vein smooth muscle cells compared to elaidic acid. Lipids. 48:395–403.
  • Mensink RP, Katan MB. 1990. Effect of dietary trans-fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 323:439–445.
  • Mori K, Ishida T, Yasuda T, Hasokawa M, Monguchi T, Sasaki M, Kondo K, Nakajima H. 2015. Serum trans-fatty acid concentration is elevated in young patients with coronary artery disease in Japan. Circ J. 79:2017–2025.
  • National Center for Health Statistics (NCHS). 2017. About the National Health and Nutrition Examination Survey. [Online]. [accessed 2017 August]. Available at: https://www.cdc.gov/nchs/nhanes/about_nhanes.htm
  • Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D, Virtamo J. 1997. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The alpha-tocopherol, betacarotene cancer pevention study. Am J Epidemiol. 145:876–887.
  • Ruth MR, Wang Y, Yu HM, Goruk S, Reaney MJ, Proctor SD, Vine DF, Field CJ. 2010. Vaccenic and elaidic acid modify plasma and splenocyte membrane phospholipids and mitogen-stimulated cytokine production in obese insulin resistant JCR: LA-cp rats. Nutrients. 2:181–197.
  • van de Vijver LP, Kardinaal AF, Couet C, Aro A, Kafatos A, Steingrimsdottir L, Amorim Cruz JA, Moreiras O, Becker W, van Amelsvoort JMM, et al. 2000. Association between trans-fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study. Eur J Clin Nutr. 54:126–135.
  • Wang Y, Jacome-Sosa MM, Ruth MR, Goruk SD, Reaney MJ, Glimm DR, Wright DC, Vine DF. 2009. Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR: LA-cp rats. J Nutr. 139: 2049–2054.
  • Wang Y, Jacome-Sosa MM, Ruth MR, Lu Y, Shen J, Reaney MJ, Scott SL, Dugan ME, Anderson HD, Field CJ, et al. 2012. The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-α and -γ in a rodent model of dyslipidemia and the metabolic syndrome. Mol Nutr Food Res. 56:1234–1246.
  • Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH. 1993. Intake of trans-fatty acids and risk of coronary heart disease among women. Lancet. 341:581–585.
  • Yang Q, Zhang Z, Loustalot F, Vesper H, Caudill SP, Ritchey M, Gillespie C, Merritt R. 2017. Plasma trans-fatty acid concentrations continue to be associated with serum lipid and lipoprotein concentrations among US adults after reductions in trans-fatty acid intake. J Nutr. 147:896–907.
  • Zapolska-Downar D, Kośmider A, Naruszewicz M. 2005. Trans-fatty acids induce apoptosis in human endothelial cells. J Physiol Pharmacol. 56:611–625.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.